Bryce Point Capital’s Intellia Therapeutics NTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-26,083
Closed -$304K 366
2024
Q4
$304K Buy
+26,083
New +$304K 0.09% 394